Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
Clinical trial NCT05149924 · COMPLETED
Trial details
- NCT number
- NCT05149924
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2019-10-17
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.